This filing is purely administrative — no new business or financial data. Monitor for future 6-K filings that contain actual operational updates, clinical trial results, or financial guidance. The historical agreements provide context on past partnerships but do not change the current investment thesis.
Price Chart
Executive Summary
Cardiol Therapeutics filed a Form 6-K on September 10, 2026, disclosing several historical agreements as exhibits: a 2017 Master Services Agreement with Dalton Pharma Services (including a 200,000-share exclusivity grant and a potential 200,000-share invention bonus), a 2018 Development Agreement with CARO (including 824,000 warrants valued at US$3,000,000), and a series of amendments to a 2018 Exclusive Supply Agreement with Noramco/Purisys (including $2.4M in raw material payments and a conditional retail exclusivity clause tied to a Shoppers Drug Mart deal). These are all legacy contracts from 2017-2020, filed now for routine exhibit compliance. No new business developments, financial results, or material changes were reported, making this a purely administrative filing with no current trading catalyst.
Key Facts
- Filed historical agreements from 2017-2020 as exhibits to Form 6-K.
- 2017 Dalton Pharma MSA included 200,000 exclusivity shares and up to 200,000 invention bonus shares.
- 2018 CARO development agreement included 824,000 warrants valued at US$3,000,000 and a US$400,000 cash payment.
- 2018 Noramco supply agreement amendments show $2.4M in raw material payments for 700KG of API.
- Amendment No. 6 to the Noramco agreement tied retail exclusivity in Canada/Mexico to a Shoppers Drug Mart deal (deadline May 31, 2020).
- No current financial results, guidance, or material corporate events were disclosed.
Financial Impact
No current financial impact; all disclosed agreements are historical (2017-2020) and filed for routine exhibit purposes.
Risk Factors
- No new material information; stock may be range-bound without a catalyst.
- Historical agreements may contain expired or renegotiated terms that are no longer relevant.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-106836 |
| Document: tm2625221d1_ex99-1.htm | 0001104659-26-106836 |
| Document: tm2625221d1_ex99-7.htm | 0001104659-26-106836 |
| Document: tm2625221d1_6k.htm | 0001104659-26-106836 |
| Document: tm2625221d1_ex99-4.htm | 0001104659-26-106836 |
| Document: tm2625221d1_ex99-3.htm | 0001104659-26-106836 |
| Document: tm2625221d1_ex99-6.htm | 0001104659-26-106836 |
| Document: tm2625221d1_ex99-5.htm | 0001104659-26-106836 |
| Document: tm2625221d1_ex99-8.htm | 0001104659-26-106836 |
| Document: 0001104659-26-106836-index-headers.html | 0001104659-26-106836 |
| Document: 0001104659-26-106836-index.html | 0001104659-26-106836 |
| Document: 0001104659-26-106836.txt | 0001104659-26-106836 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | SC 13G/A | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 23, 2026 4w ago | 6-K | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 16, 2026 5w ago | 6-K | $1.90 | awaiting T+60 | — | $1.14 (−40.00%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 9, 2026 6w ago | 6-K | $2.29 | awaiting T+60 | — | $1.14 (−50.11%) |
Aug 5, 2026 11w ago | 6-K | $1.34 | awaiting T+60 | — | $1.14 (−14.93%) |
Jul 14, 2026 15w ago | 6-K | $1.15 $1.32 | ▲ +14.78% | ▲ +11.41% | $1.14 (−0.87%) |
Jul 9, 2026 15w ago | 6-K | $0.9920 $1.41 | ▲ +42.14% | ▲ +40.50% | $1.14 (+14.92%) |
May 26, 2026 22w ago | 6-K | $1.30 $1.96 | ▲ +50.77% | ▲ +48.04% | $1.14 (−12.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers